[Preoperative radiotherapy plus resection versus surgery alone in patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicenter randomized phase III study]
- PMID: 33403443
- PMCID: PMC7892695
- DOI: 10.1007/s00066-020-01734-5
[Preoperative radiotherapy plus resection versus surgery alone in patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicenter randomized phase III study]
Comment on
-
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial.Lancet Oncol. 2020 Oct;21(10):1366-1377. doi: 10.1016/S1470-2045(20)30446-0. Epub 2020 Sep 14. Lancet Oncol. 2020. PMID: 32941794 Clinical Trial.
References
-
- Bonvalot S, Gronchi A, Le Péchoux C, et al. Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2020;21(10):1366–1377. doi: 10.1016/S1470-2045(20)30446-0. - DOI - PubMed
-
- Gronchi A, Strauss DC, Miceli R, et al. Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): a report on 1007 patients from the multi-institutional collaborative RPS working group. Ann Surg. 2016;263:1002–1009. doi: 10.1097/SLA.0000000000001447. - DOI - PubMed
-
- Nussbaum DP, Rushing CN, Lane WO, et al. Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database. Lancet Oncol. 2016;17(7):966–975. doi: 10.1016/S1470-2045(16)30050-X. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
